Your browser doesn't support javascript.
loading
Long-term safety and immunogenicity of the M72/AS01E candidate tuberculosis vaccine in HIV-positive and -negative Indian adults: Results from a phase II randomized controlled trial.
Kumarasamy, Nagalingeswaran; Poongulali, Selvamuthu; Beulah, Faith Esther; Akite, Elaine Jacqueline; Ayuk, Leo Njock; Bollaerts, Anne; Demoitié, Marie-Ange; Jongert, Erik; Ofori-Anyinam, Opokua; Van Der Meeren, Olivier.
Afiliação
  • Kumarasamy N; YRG CARE Medical Centre (YR Gaitonde Centre for AIDS Research and Education), Voluntary Health Services Campus, Taramani, Chennai, India.
  • Poongulali S; YRG CARE Medical Centre (YR Gaitonde Centre for AIDS Research and Education), Voluntary Health Services Campus, Taramani, Chennai, India.
  • Beulah FE; YRG CARE Medical Centre (YR Gaitonde Centre for AIDS Research and Education), Voluntary Health Services Campus, Taramani, Chennai, India.
  • Akite EJ; GSK, Rixensart and Wavre, Belgium.
  • Ayuk LN; GSK, Rixensart and Wavre, Belgium.
  • Bollaerts A; GSK, Rixensart and Wavre, Belgium.
  • Demoitié MA; GSK, Rixensart and Wavre, Belgium.
  • Jongert E; GSK, Rixensart and Wavre, Belgium.
  • Ofori-Anyinam O; GSK, Rixensart and Wavre, Belgium.
  • Van Der Meeren O; GSK, Rixensart and Wavre, Belgium.
Medicine (Baltimore) ; 97(45): e13120, 2018 Nov.
Article em En | MEDLINE | ID: mdl-30407329
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Soropositividade para HIV / Vacinas contra a Tuberculose Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Soropositividade para HIV / Vacinas contra a Tuberculose Idioma: En Ano de publicação: 2018 Tipo de documento: Article